Gliquidone Tablets

This product is a second-generation oral sulfonylurea hypoglycemic drug. It is a highly active pancreatic beta cell agent that binds to specific receptors on the pancreatic beta cell membrane and can induce the production of appropriate amounts of insulin to lower blood sugar concentration.

The main ingredients of this product are: Gliquidone Chemical name: 1-cyclohexyl-3-[p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxy-2-(1H)-isoquinolyl)-ethyl]phenyl]sulfonyl]urea. Molecular formula: C27H33N3O6S Molecular weight: 527.60

This product is white tablets.

Type 2 diabetes (non-insulin-dependent diabetes).

Oral administration: It should be taken half an hour before meals. The general daily dose is 15-120 mg (0.5 tablets to 4 tablets). The dose can be adjusted appropriately according to individual conditions and doctor's advice. Usually, the daily dose is within 30 mg (1 tablet) and can be taken once before breakfast. Larger doses should be taken three times before meals. The maximum daily dose should not exceed 180 mg (6 tablets).

This product is generally well tolerated, and very few people have skin allergic reactions, gastrointestinal reactions, mild hypoglycemia reactions and changes in the blood system.

It is contraindicated for patients with insulin dependence, pre-diabetic coma, diabetes combined with acidosis or ketosis, allergy to sulfonamides, and gestational diabetes.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

1. The effect of this product can be enhanced when used in combination with salicylates, sulfonamides, phenylbutazone, anti-tuberculosis drugs, tetracyclines, monoamine oxidase inhibitors, b-receptor blockers, chloramphenicol, dicoumarols and cyclophosphamide. 2. Chlorpromazine, sympathomimetic drugs, corticosteroids, thyroid hormones, oral contraceptives and nicotinic acid preparations can reduce the hypoglycemic effect of this product. This product can reduce the patient's tolerance to alcohol, and alcohol may also enhance the hypoglycemic effect of the drug.

Keep away from light and store in sealed container.

30mg

60 months.

Shenzhen Zhonglian Pharmaceutical Co., Ltd.

• Founded in:

  1988-10-11

• Address:

  Room 401, Building 1, Block B, No. 9 Danqing Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen (One license, multiple locations enterprise)

• Tax NO.:

  91440300192188676Y

• Registered Funds:

  120 million yuan

• Website:

  Log in to view

• Email:

  Log in to view